Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Covington
Merck
AstraZeneca
Medtronic
Cantor Fitzgerald
Novartis
Baxter
US Department of Justice
Harvard Business School

Generated: October 19, 2017

DrugPatentWatch Database Preview

Drug Master Files for: hydrochlorothiazide

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
456III12/11/1961INDUSTRIA CHEMICA PRODOTTI FRANCIS SPACHLOROTHIAZIDE (BULK) - HYDROCHLOROTHIAZIDE
881AII1/2/1965CAMBREX PROFARMACO MILANO SRLHYDROCHLOROTHIAZIDE
1059III5/10/1967MICRO CHEMS LTDHYDROCHLOROTHIAZIDE USP
2115AII6/14/1973TEVA PHARMACEUTICAL INDUSTRIES LTDHYDROCHLOROTHIAZIDE
2492III6/30/1975MEDIMPEX NORTHAMERICA INCDIHYDROCHLOROTHIAZIDE
4028AII12/10/1980TEVA PHARMACEUTICAL INDUSTRIES LTDHYDROCHLOROTHIAZIDE
4436III2/4/1982SMITH KLINE & FRENCH LABS DIV SMITHKLINE BECKMAN CORPHYDROCHLOROTHIAZIDE IN PHIL PA
4488III4/5/1982LABORATORIOS JULIAN DE MEXICO SAHYDROCHLOROTHIAZIDE
4508III4/6/1982ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVHYDROCHLOROTHIAZIDE
4924III4/29/1983CHANGZHOU PHARMACEUTICAL FACTORYHYDROCHLOROTHIAZIDE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Chubb
Baxter
Accenture
Healthtrust
QuintilesIMS
US Department of Justice
Harvard Business School
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot